Literature DB >> 31115097

Elevated circulating lnc-ANRIL/miR-125a axis level predicts higher risk, more severe disease condition, and worse prognosis of sepsis.

Feng Gui1, Huan Peng1, Yijue Liu1.   

Abstract

AIM: This study aimed to investigate the correlation of lnc-ANRIL/miR-125a axis with risk, severity, inflammation, and prognosis of sepsis.
METHODS: A hundred and twenty-six sepsis patients and 125 healthy controls were recruited, and then, blood samples were collected, and plasma was separated for lnc-ANRIL, miR-125a, lnc-ANRIL/miR-125a axis, and inflammatory cytokine level detections. In addition, basic characteristics, 28-day mortality, and accumulating survival of sepsis patients were recorded.
RESULTS: Plasma lnc-ANRIL expression was increased, miR-125a expression was decreased, and lnc-ANRIL/miR-125a axis level was elevated in sepsis patients compared with healthy controls, and all of them had good value for predicting sepsis risk with AUCs of 0.800, 0.817, and 0.843, respectively. Lnc-ANRIL and lnc-ANRIL/miR-125a axis were positively correlated with biochemical index levels including CRP and PCT levels, disease severity scale scores, and pro-inflammatory cytokine levels in sepsis patients, while miR-125a displayed the opposite trend. Lnc-ANRIL and lnc-ANRIL/miR-125a axis expressions were elevated, while miR-125a expression was declined in deaths compared with survivors, and all of them predicted 28-day mortality in sepsis patients with AUCs of 0.765, 0.745, and 0.785, respectively. Subsequently, the Kaplan-Meier analysis revealed that patients with high lnc-ANRIL, low miR-125a, and high lnc-ANRIL/miR-125a axis levels presented with worse accumulating survival. In addition, multivariate regression model analyses revealed that high plasma lnc-ANRIL/miR-125a axis was an independent predictive factor for both increased 28-day mortality and worse accumulating survival.
CONCLUSION: Circulating lnc-ANRIL/miR-125a axis was upregulated and could serve as a biomarker for severity, inflammation, and prognosis in sepsis patients.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  Lnc-ANRIL/miR-125a axis; inflammation; prognosis; risk; sepsis; severity

Mesh:

Substances:

Year:  2019        PMID: 31115097      PMCID: PMC6642292          DOI: 10.1002/jcla.22917

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  35 in total

1.  TLR-4/microRNA-125a/NF-κB signaling modulates the immune response to Mycobacterium tuberculosis infection.

Authors:  Wenyi Niu; Bing Sun; Mingying Li; Junwei Cui; Jian Huang; Ligong Zhang
Journal:  Cell Cycle       Date:  2018-09-06       Impact factor: 4.534

2.  Anti-aging activity of the Ink4/Arf locus.

Authors:  Ander Matheu; Antonio Maraver; Manuel Collado; Isabel Garcia-Cao; Marta Cañamero; Consuelo Borras; Juana M Flores; Peter Klatt; Jose Viña; Manuel Serrano
Journal:  Aging Cell       Date:  2009-04       Impact factor: 9.304

Review 3.  MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.

Authors:  Kobina Essandoh; Yutian Li; Jiuzhou Huo; Guo-Chang Fan
Journal:  Shock       Date:  2016-08       Impact factor: 3.454

4.  LncRNA ANRIL promotes NLRP3 inflammasome activation in uric acid nephropathy through miR-122-5p/BRCC3 axis.

Authors:  Jiacai Hu; Hao Wu; Daochun Wang; Zhijie Yang; Junjun Dong
Journal:  Biochimie       Date:  2018-10-19       Impact factor: 4.079

5.  Circulating lncRNA IFNG-AS1 expression correlates with increased disease risk, higher disease severity and elevated inflammation in patients with coronary artery disease.

Authors:  Yahuan Xu; Bibo Shao
Journal:  J Clin Lab Anal       Date:  2018-05-09       Impact factor: 2.352

6.  Knockdown of ANRIL aggravates H2O2-induced injury in PC-12 cells by targeting microRNA-125a.

Authors:  Ran Li; Fei Yin; Ying-Ying Guo; Kun-Chi Zhao; Qing Ruan; Ying-Mei Qi
Journal:  Biomed Pharmacother       Date:  2017-06-09       Impact factor: 6.529

Review 7.  Rapid diagnosis of sepsis.

Authors:  Frank Bloos; Konrad Reinhart
Journal:  Virulence       Date:  2013-12-11       Impact factor: 5.882

Review 8.  Non-coding RNA: a potential biomarker and therapeutic target for sepsis.

Authors:  Tie-Ning Zhang; Da Li; Jing Xia; Qi-Jun Wu; Ri Wen; Ni Yang; Chun-Feng Liu
Journal:  Oncotarget       Date:  2017-10-10

9.  miRNA-125a modulates autophagy of thyroiditis through PI3K/Akt/mTOR signaling pathway.

Authors:  Danyan Chen; Xiaolong Huang; Song Lu; Huacong Deng; Hua Gan; Rongxi Huang; Binghan Zhang
Journal:  Exp Ther Med       Date:  2019-02-12       Impact factor: 2.447

10.  Long non-coding RNA ANRIL-mediated inflammation response is involved in protective effect of rhein in uric acid nephropathy rats.

Authors:  Jiacai Hu; Daochun Wang; Hao Wu; Zhijie Yang; Na Yang; Junjun Dong
Journal:  Cell Biosci       Date:  2019-01-17       Impact factor: 7.133

View more
  12 in total

1.  Elevated circulating lnc-ANRIL/miR-125a axis level predicts higher risk, more severe disease condition, and worse prognosis of sepsis.

Authors:  Feng Gui; Huan Peng; Yijue Liu
Journal:  J Clin Lab Anal       Date:  2019-05-21       Impact factor: 2.352

Review 2.  Non-Coding RNA Networks as Potential Novel Biomarker and Therapeutic Target for Sepsis and Sepsis-Related Multi-Organ Failure.

Authors:  Domenico Di Raimondo; Edoardo Pirera; Giuliana Rizzo; Irene Simonetta; Gaia Musiari; Antonino Tuttolomondo
Journal:  Diagnostics (Basel)       Date:  2022-05-31

Review 3.  Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis.

Authors:  Wei Wang; Ni Yang; Ri Wen; Chun-Feng Liu; Tie-Ning Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

Review 4.  Non-coding RNAs and Exosomes: Their Role in the Pathogenesis of Sepsis.

Authors:  Seyed MohammadReza Hashemian; Mohammad Hossein Pourhanifeh; Sara Fadaei; Ali Akbar Velayati; Hamed Mirzaei; Michael R Hamblin
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-15       Impact factor: 8.886

Review 5.  Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review.

Authors:  Tatiana Barichello; Jaqueline S Generoso; Mervyn Singer; Felipe Dal-Pizzol
Journal:  Crit Care       Date:  2022-01-06       Impact factor: 9.097

Review 6.  Long Non-Coding RNAs as Biomarkers and Therapeutic Targets in Sepsis.

Authors:  Chuqiao Wang; Guorui Liang; Jieni Shen; Haifan Kong; Donghong Wu; Jinxiang Huang; Xuefeng Li
Journal:  Front Immunol       Date:  2021-09-22       Impact factor: 7.561

7.  Long non-coding RNA MALAT1/microRNA 125a axis presents excellent value in discriminating sepsis patients and exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients.

Authors:  Wei Liu; Feng Geng; Li Yu
Journal:  J Clin Lab Anal       Date:  2020-04-20       Impact factor: 2.352

Review 8.  The Role of Long Non-coding RNAs in Sepsis-Induced Cardiac Dysfunction.

Authors:  Jiawen Li; Yulin Zhang; Donghui Zhang; Yifei Li
Journal:  Front Cardiovasc Med       Date:  2021-05-10

Review 9.  Regulatory Role of Non-Coding RNAs on Immune Responses During Sepsis.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Normohammad Arefian
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

10.  Long noncoding RNA NEAT 1 and its target microRNA-125a in sepsis: Correlation with acute respiratory distress syndrome risk, biochemical indexes, disease severity, and 28-day mortality.

Authors:  Yongkai Yang; Liu Yang; Zhenqing Liu; Yujun Wang; Junhui Yang
Journal:  J Clin Lab Anal       Date:  2020-08-12       Impact factor: 3.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.